Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
WNT1-inducible signaling pathway protein 1 (WISP1), also known as CCN4, is a secreted matricellular protein and a member of the CCN family of extracellular matrix-associated signaling proteins. It regulates diverse cellular processes including cell adhesion, proliferation, differentiation, survival, motility, tissue repair, and wound healing. WISP1 plays a significant role in organ development, tissue regeneration, cytoprotection, and extracellular matrix production. It is implicated in various diseases including cancer, fibrosis, inflammation, and vascular disease.
WISP1 interacts with multiligand receptors like integrins to regulate intracellular pathways including FAK, RAS/RAF/MEK/ERK, NF-κB, TGF-β, and PI3K/AKT.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on WNT1-inducible signaling pathway protein 1 (WISP1).